View Older Stories View More Recent Stories

Apr 26, 2017 04:01PM REGENXBIO Announces Full Exercise and Closing of Underwriters’ Option to Purchase Additional Shares
Apr 24, 2017 12:01PM Chardan Capital Markets Reiterates Sell Rating and $6.50 PT on Akari Therapeutcis (AKTX); 'Weak Efficacy for Coversin in the Ph2 PNH COBALT Trial'
Apr 21, 2017 09:42AM SRAX Announces Offering of $3.72 Million of Secured Convertible Debentures
Apr 17, 2017 05:55AM Akari Therapeutics (AKTX) PT Raised to $6.50 at Chardan Capital Markets; 'Skepticism on Coversin in PNH'
Apr 12, 2017 04:34PM Forum Merger Corporation Completes $150,000,000 Initial Public Offering
Apr 12, 2017 08:38AM PlacementTracker Publishes Q1 2017 Private Placement Market League Tables
Apr 12, 2017 06:29AM Lion Biotechnologies (LBIO): Reiterating Buy - Chardan
Apr 11, 2017 05:55AM Regenxbio Inc. (RGNX) PT Raised to $50 at Chardan Capital Markets on News Dr. Olivier Danos is New CSO; 'Watershed Moment'
Apr 10, 2017 04:01PM Ohr Pharmaceutical Announces Closing of Public Offering of Common Stock and Warrants
Apr 6, 2017 08:01PM Forum Merger Corporation Announces Pricing of $150 Million Initial Public Offering
Apr 5, 2017 09:24AM Ohr Pharmaceutical (OHRP) Prices $14.175M Offering of Common Stock and Warrants
Apr 5, 2017 09:23AM Ohr Pharmaceutical Announces Pricing of $14.175 Million Public Offering of Common Stock and Warrants
Apr 4, 2017 04:03PM Ohr Pharmaceutical (OHRP) Reports Proposed Equity Offering
Apr 4, 2017 04:01PM Ohr Pharmaceutical Announces Proposed Public Offering of Common Stock and Warrants
Apr 4, 2017 09:29AM Pre-Open Movers 04/04: (GNCMA) (PRTK) (CYCC) Higher; (AYI) (KATE) (NVDA) Lower (more...)
Apr 4, 2017 06:00AM Chardan Capital Markets Upgrades Arbutus Biopharma (ABUS) to Buy
Mar 31, 2017 09:00AM WPCS Closes $968,000 Financing
Mar 30, 2017 06:32AM Ritter Pharma (RTTR): Cutting PT After Phase II Data Fails To Meet Endpoint - Chardan
Mar 28, 2017 09:29AM Pre-Open Movers 03/28: (PSIX) (CARA) (SB) Higher; (CYRX) (ORIG) (MEET) Lower (more...)
Mar 28, 2017 09:11AM Biocept (BIOC) to Sell 4.32M Shares at $2.15 with Warrants
Mar 28, 2017 09:10AM Biocept Announces Pricing of $9.3 Million Financing
Mar 27, 2017 05:56PM After-Hours Stock Movers 03/27: (PSIX) (OCN) (RHT) Higher; (CYRX) (EVH) (STOR) Lower (more...)
Mar 27, 2017 04:33PM Chardan Capital Markets Starts CRISPR Therapeutics (CRSP) at Buy
Mar 27, 2017 04:31PM Chardan Capital Markets Starts Editas Medicine (EDIT) at Buy
Mar 27, 2017 04:30PM Chardan Capital Markets Starts Intellia Therapeutics (NTLA) at Buy
Mar 27, 2017 06:18AM Teladoc (TDOC): Management Confident on NDR - Chardan
Mar 23, 2017 08:01AM La Jolla Pharmaceutical (LJPC) Prices 3.7M Common Stock Offering at $33.50/Share
Mar 23, 2017 08:00AM La Jolla Pharmaceutical Company Announces Pricing of Public Offering of Common Stock
Mar 22, 2017 06:30AM HealthEquity, Inc (HQY) PT Raised to $53 at Chardan Capital Markets Following Q4 Beat and Positive Guidance
Mar 22, 2017 05:36AM Regenxbio (RGNX) Reports Pricing of 3.7M Share Offering at $20.50
Mar 21, 2017 09:31PM REGENXBIO Announces Pricing of Public Offering of Common Stock
Mar 21, 2017 04:03PM Regenxbio (RGNX) Plans $75M Common Stock Offering
Mar 21, 2017 04:01PM REGENXBIO Announces Proposed Public Offering of Common Stock
Mar 15, 2017 07:18AM Chardan Capital Markets Reiterates Buy on Benefitfocus (BNFT) Following Analyst Day
Mar 13, 2017 08:29AM Chardan Capital Markets Reiterates Buy on Cogent (COGT) Following 4Q
Mar 13, 2017 05:56AM Profire Energy (PFIE) PT Raised to $2.15 at Chardan Capital Markets; Estimates Raised
Mar 7, 2017 12:00PM Chardan Capital Maintains Buy Rating and $3.50 PT on 22nd Century Group (XXII) Ahead of Q4 Report
Mar 7, 2017 06:35AM Chardan Capital Maintains Buy Rating and $10 PT on Vuzix Corp. (VUZI); 'Strong Start to 2017 from M300 and Toshiba'
Mar 2, 2017 07:15AM Chardan Capital Reiterates Buy Rating and $11.50 PT on ORBCOMM (ORBC); 'Strong Backlog and Robust Pipeline'
Mar 2, 2017 07:02AM Teladoc (TDOC) PT Raised to $28 at Chardan Capital Markets Following 4Q Top-Line and Bottom-Line Beats
Mar 2, 2017 06:02AM La Jolla Pharma (LJPC) PT Raised to $90 at Chardan Capital Markets Following Robust LJPC-501 Phase 3 Topline Results
Feb 28, 2017 06:03AM Chardan Capital Maintains Hold Rating and $1.50 PT on Novavax (NVAX) Following 4Q Report; New RSV F Clinical Data is Next Catalyst
Feb 24, 2017 07:27AM Chardan Capital Markets Upgrades Globalstar (GSAT) to Buy
Feb 23, 2017 06:53AM Chardan Capital Markets Starts OncoCyte Corp (OCX) at Buy
Feb 21, 2017 08:12AM Chardan Capital Markets Reiterates Buy on NICE Systems (NICE) Following 4Q Report
Feb 21, 2017 06:58AM Chardan Capital Reiterates Neutral Rating and $35 PT on DigitalGlobe (DGI) Following Takeover Reports
Feb 21, 2017 06:27AM Teladoc (TDOC): More Confident After Management Meetings - Chardan
Feb 15, 2017 04:05PM BioTime, Inc. Announces Closing of Public Offering of Common Stock
Feb 14, 2017 08:55AM Chardan Capital Markets Remains Bullish on NICE Systems (NICE) Ahead of 4Q Report
Feb 14, 2017 08:29AM Chardan Capital Markets Upgrades Sage Therapeutics (SAGE) to Neutral
View More Recent Stories View Older Stories